Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
Open Access
- 22 January 2016
- journal article
- research article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 6 (1) , e389
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Results of a Phase II Randomizing Intensified Rituximab Pre-Phase Followed By Standard FCR Vs Standard FCR in Previously Untreated Patients with Active B-Chronic Lymphocytic Leukemia (B-CLL). CLL2010FMP (for fit medically patients): A Study of the french Cooperative Group on CLL and WM (FCGCLL/MW) and the “Groupe Ouest-Est d’Etudes Des Leucémies Aigües Et Autres Maladies Du sang” (GOELAMS)Blood, 2014
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting ConditionsNew England Journal of Medicine, 2014
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive functionLeukemia, 2012
- Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in miceJournal of Clinical Investigation, 2011
- Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cellsBlood, 2011
- Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized TherapiesClinical Cancer Research, 2011
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progressionJournal of Clinical Investigation, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa geneBlood, 2002